179 related articles for article (PubMed ID: 10442375)
1. Adjuvant treatment of early stage non-small-cell lung cancer.
Wada H
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):102-5. PubMed ID: 10442375
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for resected non-small cell lung cancer.
Wakelee H; Chhatwani L
Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant chemotherapy for non-small cell lung cancer].
Otake Y; Tanaka F; Wada H; Hitomi S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
10. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy in NSCLC (stages I to III).
Coleman MH; Bueno R
Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
[TBL] [Abstract][Full Text] [Related]
13. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
14. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Bunn PA
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
[TBL] [Abstract][Full Text] [Related]
15. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
16. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
[TBL] [Abstract][Full Text] [Related]
17. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
Riquet M; Berna P
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M
N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Dunant A; Pignon JP; Le Chevalier T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
[TBL] [Abstract][Full Text] [Related]
20. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
Berghmans T
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
